COMMUNIQUÉS West-GlobeNewswire

Cartesian Therapeutics to Participate in Upcoming Investor Conferences
06/03/2024
GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today [...]
Psyence Biomedical’s Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
06/03/2024
NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (NASDAQ:PBM) ("Psyence Biomed" or the "Company") is pleased to announce that its wholly-owned subsidiary, Psyence Australia (Pty) Ltd ("Psyence [...]
Breckenridge Brewery Channels the Luck of The Irish With Nitro Irish Stout and Go Gold Sweepstakes
06/03/2024
Win a Trip for Two to Ireland LITTLETON, Colo., March 06, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery (“Breck Brew”) , a subsidiary of Tilray Brands, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY and TSX: TLRY), [...]
Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
06/03/2024
Pre-clinical data on Medicenna’s first-in-class Masked and Tumor Targeted Bifunctional Superkine, MDNA113, will also be presented at the Annual Meeting TORONTO and HOUSTON, March 06, 2024 (GLOBE NEWSWIRE) -- Medicenna [...]
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
06/03/2024
- Multiple clinical milestones across portfolio anticipated in 2024, including two Phase 2 trials assessing belrestotug + dostarlimab in 1L NSCLC and 1L HNSCC - Completed enrollment of third dose cohort in Phase 1 trial [...]
Interactive Strength Inc. (Nasdaq: TRNR) to Exhibit Both CLMBR and FORME Lift at IHRSA in Los Angeles March 6-8
06/03/2024
CLMBR is Receiving Significant Interest From Gyms for use on the Cardio Floor and in the Group Fitness Room as a Replacement for Spin Bike FORME is Receiving the Highest Interest From Country Clubs and Multi-family [...]
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability
06/03/2024
Total Revenues for Fiscal Year 2023 of $142.5 Million, Representing All-Time Record Annual Revenues and Up 10% Compared to Fiscal Year 2022 Fiscal Year 2023 Adjusted EBITDA of $24.1 Million, Up 35% Year-over-Year Strong [...]
ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors
06/03/2024
New translational data from a head-to-head study of eblasakimab and dupilumab in a human tissue model of COPD shows eblasakimab performed better than dupilumab in improving airway function and enhancing bronchodilation [...]
Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements
06/03/2024
In vivo Proof-of-Concept demonstrated for its off-the-shelf miCAR7 T-cell product, data presented at the 7 th CAR-TCR Summit Europe Milestone achieved in its collaboration with Allogene Therapeutics GENEVA, March 06, [...]
Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses
06/03/2024
ZUG, Switzerland, March 06, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks [...]
Cingulate to Attend DCAT Week 2024 in New York City
06/03/2024
Will Host Licensing Meetings with Multiple Parties to Discuss Assets, Pipeline and Technology KANSAS CITY, Kan., March 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) , a biopharmaceutical company utilizing [...]
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
06/03/2024
MAINZ, Germany, March 6, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth quarter 2023 on Wednesday, March 20, 2024. [...]
Enterome Announces Upcoming Presentation on OncoMimics™ Approach to Cancer Immunotherapy at the AACR Annual Meeting 2024
06/03/2024
PARIS, March 06, 2024 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry [...]
Affimed Announces 1-for-10 Reverse Stock Split
06/03/2024
MANNHEIM, Germany, March 06, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight [...]
Nexstim Plc Publishes 2023 Annual Report
06/03/2024
Company announcement, Helsinki, 6 March 2024 at 1 PM (EET) Nexstim Plc Publishes 2023 Annual Report Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces the publication of its 2023 Annual Report. These documents [...]
Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting
06/03/2024
Planegg/Martinsried, March 6, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]
Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team
06/03/2024
BBS-Bioactive Bone Substitutes Plc, Company announcement, 6 March 2024 at 11:15 a.m. Changes in the BBS-Bioactive Bone Substitutes Plc’s Management Team Oy Jamerco Ltd. has terminated its service contract with BBS- [...]
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023
06/03/2024
Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, March 06, [...]
Health technology leader Philips recognized as Clarivate Top 100 Global Innovator
06/03/2024
March 6, 2024 Company’s innovative products and solutions improved the lives of 1.9 billion people in 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has [...]

Pages